Article Versions Notes

Triantopoulou S, Roupa I, Shegani A, Pirmettis NN, Terzoudi GI, Chiotellis A, Tolia M, Damilakis J, Pirmettis I, Paravatou-Petsota M. Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting. Pharmaceutics. 2024; 16(9):1213. https://doi.org/10.3390/pharmaceutics16091213

Triantopoulou, Sotiria, Ioanna Roupa, Antonio Shegani, Nektarios N. Pirmettis, Georgia I. Terzoudi, Aristeidis Chiotellis, Maria Tolia, John Damilakis, Ioannis Pirmettis, and Maria Paravatou-Petsota. 2024. "Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting" Pharmaceutics 16, no. 9: 1213. https://doi.org/10.3390/pharmaceutics16091213

Triantopoulou, S., Roupa, I., Shegani, A., Pirmettis, N. N., Terzoudi, G. I., Chiotellis, A., Tolia, M., Damilakis, J., Pirmettis, I., & Paravatou-Petsota, M. (2024). Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting. Pharmaceutics, 16(9), 1213. https://doi.org/10.3390/pharmaceutics16091213